Bibliography
Export 217 results:
Filters: Keyword is *Tissue Donors [Clear All Filters]
Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997;3(1):45-9.
Transferral of extrathoracic donor neoplasm by the cardiac allograft. J Heart Lung Transplant. 1997;16(3):298-301.
Transmission of cancer from organ donors. Ann Transplant. 1997;2(4):7-12.
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology//Gastroenterology. 1997;113(5):1668-74.
The value of routine donor corneal rim cultures in penetrating keratoplasty. Arch Ophthalmol. 1997;115(6):719-24.
Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion. 1996;36(7):596-600.
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.[Erratum appears in Transfusion 1997 Jan;37(1):109]. Transfusion. 1996;36(7):590-5.
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplantation. 1996;18(6):1073-9.
Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol. 1996;93(1):163-5.
Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11(8):1668-73.
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int. 1996;9(4):426-9.
Thrombocytopenia in allogeneic peripheral blood stem cell collections. Transfusion. 1996;36(7):668-9.
Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109(4):1119-24.
Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors. Surv Ophthalmol. 1995;40(1):80.
Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report. Am J Kidney Dis. 1995;26(1):84-7.
Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant. 1995;4(5):455-77.
Outcome of corneal grafting with donor tissue from eyes with primary choroidal melanomas. A retrospective cohort comparison. Arch Ophthalmol. 1995;113(6):753-6.
Poor correlation between reactive syphilis serology and human immunodeficiency virus testing among potential cornea donors. Am J Ophthalmol. 1995;119(1):1-6.
Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 1995;103(6):748-55.
Transplant and organ donor-associated transmission of human T-lymphotropic virus types I and II. Transplant Proc. 1995;27(4):2417.
Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea. 1995;14(6):547-53.
Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea. 1994;13(4):294-304.
Liver infested with Clonorchis sinensis in orthotopic liver transplantation: a case report. Transplant Proc. 1994;26(4):2269-71.